A retrospective randomized study of asthma control in the US: results of the CHARIOT study
Philip Marcus(St. Francis Hospital), Renée J.G. Arnold(Long Island University), Sean Ekins(Collaborative Drug Discovery (United States)), Don A. Bukstein(Institute for Asthma and Allergy), Patricia Sacco(Novartis (United States)), Marc Massanari(Novartis (United States)), S. Stanley Young(National Laboratory of the Rockies), James F. Donohue(University of North Carolina at Chapel Hill)
Cited by 29
Related Papers
<i>In silico</i> pharmacology for drug discovery: methods for virtual ligand screening and profiling
|British Journal of Pharmacology|2007|693
The economic impact of allergic rhinitis and current guidelines for treatment
|Annals of Allergy Asthma & Immunology|2011|268
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma
|Journal of Allergy and Clinical Immunology|2010|230
Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites
|Molecular Pharmacology|2007|146
CATMoS: Collaborative Acute Toxicity Modeling Suite
|Environmental Health Perspectives|2021|145